Envista Holdings Corporation (NVST) Earnings Call Analysis

NYSE · Healthcare · Medical Instruments & Supplies

22/25

Growth 5 Margin 5 Expansion 5 Platform 2 Financial 5

latest quarter score

Earnings Reports

22
Envista (NVST) Q2 2026: EBITDA Margin Expands 230 bps as Balanced Growth Outpaces Dental Market
August 06, 2026
18
Invista (NVST) Q4 2025: EBITDA Margin Expands 190bps as Innovation and Cost Actions Drive Outperformance
June 15, 2026
22
Invista Holdings (NVST) Q1 2026: $300M Buyback Extension Underscores Margin-Driven Momentum
May 07, 2026
20
Envista (NVST) Q3 2025: Spark Margin Inflection Adds 540bps, Unlocks Portfolio Leverage
October 31, 2025
19
Invista (NVST) Q2 2025: Core Growth Accelerates to 5.6% as Margin Expansion Outpaces Tariff Headwinds
August 01, 2025
15
Invista (NVST) Q1 2025: Tariff Exposure Drives Supply Shift as $19M Buyback Signals Balance Sheet Strength
July 04, 2025

Browse all companies